Corient Private Wealth LLC decreased its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 1.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 631,367 shares of the financial services provider’s stock after selling 7,485 shares during the period. Corient Private Wealth LLC owned approximately 0.11% of Aflac worth $65,309,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of AFL. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Aflac by 6.4% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,694,511 shares of the financial services provider’s stock worth $524,846,000 after acquiring an additional 281,148 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in Aflac by 1.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider’s stock valued at $333,768,000 after purchasing an additional 47,119 shares in the last quarter. Amundi lifted its stake in Aflac by 81.1% during the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock worth $285,181,000 after purchasing an additional 1,232,683 shares during the last quarter. Guinness Asset Management LTD boosted its holdings in shares of Aflac by 5.2% in the 4th quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider’s stock worth $247,682,000 after purchasing an additional 118,720 shares in the last quarter. Finally, Assetmark Inc. raised its holdings in shares of Aflac by 2.0% during the 4th quarter. Assetmark Inc. now owns 1,616,772 shares of the financial services provider’s stock valued at $167,239,000 after buying an additional 32,220 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.
Aflac Trading Up 2.2 %
NYSE:AFL opened at $107.44 on Monday. The company has a 50-day moving average price of $105.37 and a 200-day moving average price of $107.68. The stock has a market cap of $58.72 billion, a price-to-earnings ratio of 11.19, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50.
Wall Street Analyst Weigh In
AFL has been the topic of several research reports. Barclays decreased their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company decreased their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 19th. Morgan Stanley upped their price target on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Evercore ISI decreased their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. Finally, BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $103.36.
Insiders Place Their Bets
In related news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now owns 49,962 shares of the company’s stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is owned by corporate insiders.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- Using the MarketBeat Dividend Yield Calculator
- How to Build the Ultimate Everything ETF Portfolio
- Should You Invest in Penny Stocks?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Makes a Stock a Good Dividend Stock?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.